Skip NavigationSkip to Content

Skewed lymphocyte subpopulations and associated phenotypes in patients with mastocytosis

  1. Author:
    Kulinski, Joseph M
    Eisch, Robin
    Young,Michael
    Rampertaap, Shakuntala
    Stoddard, Jennifer
    Monsale, Joseph
    Romito, Kimberly
    Lyons, Jonathan J
    Rosenzweig, Sergio D
    Metcalfe, Dean D
    Komarow, Hirsh D
  2. Author Address

    Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Clinical Research Directorate, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Maryland, United States of America., Immunology Service, Department of Laboratory Medicine, National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, Maryland, United States of America., Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America. Electronic address: komarowh@niaid.nih.gov.,
    1. Year: 2020
    2. Date: JAN
    3. Epub Date: 2019 07 15
  1. Journal: The journal of allergy and clinical immunology. In practice
    1. 8
    2. 1
    3. Pages: 292-+
  2. Type of Article: Article
  3. ISSN: 2213-2198
  1. Abstract:

    Mastocytosis is a clonal mast cell disorder associated with elevated mast cell mediators which themselves have been reported to affect lymphocyte function. However, the impact of an expanded mast cell compartment upon lymphocyte subpopulations, and their correlation with clinical phenotypes in patients with indolent systemic mastocytosis (ISM) has not been explored. The goal of this prospective study is to examine the immunophenotype of circulating lymphocytes in patients with ISM compared to healthy adult controls and examine relationships with aspects of clinical disease. We examined lymphocyte subsets in 20 adult patients with ISM and 40 healthy adult volunteers by multiparameter flow cytometry. Results were correlated with clinical characteristics. Patients with ISM exhibited a significantly lower median frequency and absolute cell count of both circulating CD8+ T cells and Natural Killer cells accompanying a significantly increased ratio of CD4+/CD8+ T cells when compared to healthy volunteers. Stratification of our ISM patient cohort according to clinical manifestations revealed that CD19+CD21lowCD38low B cells were significantly higher in patients with a history of autoimmune disease and counts of terminally differentiated CD4+ T cells were significantly higher in patients with osteoporosis or osteopenia. Several circulating lymphocyte subpopulations in patients with ISM were significantly different when compared to healthy controls; and in specific lymphocyte subsets, this lymphocyte skewing correlated with clinical observations including osteoporosis and autoimmune disease. These data suggest the need for further studies on abnormalities in lymphocyte subsets and the attendant clinical consequences in both mast cell proliferative and activation disorders. Copyright © 2019. Published by Elsevier Inc.

    See More

External Sources

  1. DOI: 10.1016/j.jaip.2019.07.004
  2. PMID: 31319217
  3. WOS: 000507942100034
  4. PII : S2213-2198(19)30620-8

Library Notes

  1. Fiscal Year: FY2018-2019
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel